(Q36792518)

16 August 2017

1 reference

title

Executive summary of the African-American Initiative (English)

1 reference

16 August 2017

1

Clyde W Yancy

1 reference

16 August 2017

publication date

8 February 2007

1 reference

MedGenMed : Medscape general medicine

16 August 2017

published in

1 reference

16 August 2017

volume

9

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

28

1 reference

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

16 August 2017

cites work

1 reference

12 December 2020

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994

1 reference

12 December 2020

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

12 December 2020

Drug treatment of hypertension complicating diabetes mellitus.

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.

1 reference

12 December 2020

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

12 December 2020

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

12 December 2020

The disproportionate impact of hypertensive cardiovascular disease in African Americans: getting to the heart of the issue

1 reference

12 December 2020

Physiology, genetics, and cardiovascular disease: focus on African Americans

1 reference

12 December 2020

Managing hypertension in African-American patients

1 reference

12 December 2020

Slowing cardiovascular disease progression in African-American patients: diabetes management

1 reference

12 December 2020

Improving outcomes in the post-myocardial infarction setting

1 reference

12 December 2020

Heart failure management in African Americans: meeting the challenge

1 reference

12 December 2020

Hypertension and end-organ disease in African Americans: case presentations

1 reference

12 December 2020

Cardiovascular disease in African Americans

1 reference

12 December 2020

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

1 reference

12 December 2020

Cardiovascular disease in African Americans. Closing the knowledge, treatment, and outcome gap.

1 reference

12 December 2020

Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions.

1 reference

12 December 2020

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

1 reference

12 December 2020

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

12 December 2020

Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial

1 reference

12 December 2020

Retrospective analysis: consensus statement of the hypertension in African Americans working group of the International Society on Hypertension in Blacks (ISHIB).

1 reference

12 December 2020

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.

1 reference

12 December 2020

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group

1 reference

12 December 2020

Prevention of sudden cardiac death with beta blockers.

1 reference

12 December 2020

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

12 December 2020

Heart failure in African Americans: a cardiovascular engima

1 reference

12 December 2020

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Sudden cardiac death in the United States, 1989 to 1998.

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks

1 reference

12 December 2020

Racial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter?

1 reference

12 December 2020

Identifiers

1 reference